bosentan
NDC 70771-1908, bosentan, tablet, for suspension, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1908
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213981
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1908 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BOSENTAN32 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1908-8 | 70771190808 | 4 BLISTER PACK in 1 CARTON (70771-1908-8) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70771-1908-7) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b88cc559-93ae-42db-9c38-fb5e9c4802e6
Use it
Look up 70771-1908 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1908 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1908. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.